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Abstract 
Short communication on dic(9;16)(p13;q11) 
PAX5/?, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
Acute lymphoblastic leukemia (ALL) 
Epidemiology 
Only one case to date, a 15-year old boy with a pre-
B-ALL (Coyaud et al., 2010). 
Cytogenetics 
Cytogenetics morphological 
The dic(9;16) was the sole abnormality within a 
subclone. 






391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391).  
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry 
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments. Activates 
the surface cell receptor CD19 and repress FLT3. 
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and 
PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 
Medvedovic et al., 2011). 




Truncation of PAX5 after exon 5. The region in 
16q11 does not contain any gene. 
Fusion protein 
Description 
256 amino acids. The truncated protein contains the 
DNA binding paired domain and octapeptide of 
PAX5 (201 aa) and 55 aa from contiguous introns. 
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